Abingworth closes 11th life sciences fund on $105m

Many investors in the Abingworth Clinical Co-Development Fund were family offices and funds of funds.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this